Focusing on the role of protein kinase mTOR in endometrial physiology and pathology: insights for therapeutic interventions

Mol Biol Rep. 2024 Feb 24;51(1):359. doi: 10.1007/s11033-023-08937-w.

Abstract

The mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase crucial for cellular differentiation, proliferation, and autophagy. It shows a complex role in the endometrium, influencing both normal and pathogenic conditions. mTOR promotes the growth and maturation of endometrial cells, enhancing endometrial receptivity and decidualization. However, it also contributes to the development of endometriosis (EMs) and endometrial cancer (EC), thus emerging as a therapeutic target for these conditions. In this review, we summarize recent research progress on the mTOR signalling pathway in the endometrium. This provides insights into female endometrial structure and function and guides the prevention and treatment of related diseases.

Keywords: Decidualization; Endometrial cancer; Endometrial receptivity; Endometriosis; Endometrium; mTOR.

Publication types

  • Review

MeSH terms

  • Animals
  • Endometriosis* / metabolism
  • Endometrium / metabolism
  • Female
  • Humans
  • Mammals / metabolism
  • Protein Serine-Threonine Kinases / metabolism
  • Signal Transduction
  • Sirolimus* / therapeutic use
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • Sirolimus
  • TOR Serine-Threonine Kinases
  • Protein Serine-Threonine Kinases